iifl-logo

Nippon India Pharma Fund G

Nippon India Pharma Fund G

Fund Name

Nippon India Mutual Fund

Scheme Name

Nippon India Pharma Fund G

AMC

Nippon India Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

10-May-2004

Fund Manager

Sailesh Raj Bhan

Net Assets (Rs. cr)

8346.49

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Nippon India Pharma Fund G - Nav Details

Nav Date

:  10-Dec-2025

NAV [Rs.]

:  507.8291

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

Nippon India Pharma Fund G- NAV Chart

Nippon India Pharma Fund G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
-1.28
-0.89
-1.44
-0.97
-0.98
21.02
15.65
20.01
Category Avg
-1.63
-1.5
-1.6
1.24
-1.52
22.35
16.18
13.93
Category Best
-1.34
-0.46
0.6
5.89
5.27
27.79
19.04
29.71
Category Worst
-2.65
-3.14
-3.48
-3.57
-8.41
18.45
12.07
-5.69

Nippon India Pharma Fund G- Latest Dividends

No Records Found

Nippon India Pharma Fund G- Investment Details

Min. Investment(Rs.)

5000

Increm.Investment(Rs.)

1000

In & Out

In

InName Of The CompanyNo Of Shares
--

Out

InName Of The CompanyNo Of Shares
--

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology13.5562563491,145.91
EquityLupinPharmaceuticals & Biotechnology7.593083991642.14
EquityDivi's Lab.Pharmaceuticals & Biotechnology6.90900754583.41
EquityCiplaPharmaceuticals & Biotechnology6.333495054535.19
EquityDr Reddy's LabsPharmaceuticals & Biotechnology5.833916074492.95
EquityApollo HospitalsHealthcare Services5.63648795475.92
EquityMedplus HealthRetailing3.473627277293.37
EquityVijaya Diagnost.Healthcare Services3.412886684288.10
EquityAjanta PharmaPharmaceuticals & Biotechnology2.90959323245.66
EquityGlaxosmi. PharmaPharmaceuticals & Biotechnology2.77913226234.65
EquityGland PharmaPharmaceuticals & Biotechnology2.751320549232.36
EquitySai LifePharmaceuticals & Biotechnology2.672555745226.03
EquityThyrocare Tech.Healthcare Services2.574392120217.71
EquityAurobindo PharmaPharmaceuticals & Biotechnology2.471702630208.86
EquityAbbott IndiaPharmaceuticals & Biotechnology2.4468677206.54
EquityDr Lal PathlabsHealthcare Services2.20609112185.88
EquityAlkem LabPharmaceuticals & Biotechnology2.18323678184.01
EquityNarayana HrudayaHealthcare Services2.12923911179.74
EquityJ B Chemicals &Pharmaceuticals & Biotechnology2.09999649177.06
EquityMankind PharmaPharmaceuticals & Biotechnology2.02757496170.51
EquityBioconPharmaceuticals & Biotechnology1.994219374168.07
EquityIpca Labs.Pharmaceuticals & Biotechnology1.931124164163.35
EquityPfizerPharmaceuticals & Biotechnology1.87318249158.32
EquitySuraksha Diagno.Healthcare Services1.353896349114.04
EquityEmcure PharmaPharmaceuticals & Biotechnology1.24740259104.69
EquityMax HealthcareHealthcare Services1.23891340103.64
EquityFortis Health.Healthcare Services1.201103889101.45
EquitySanofi IndiaPharmaceuticals & Biotechnology1.19230272101.03
EquitySanofi ConsumerPharmaceuticals & Biotechnology1.1821365999.55
EquitySyngene Intl.Healthcare Services0.98128049283.01
EquityAnthem BiosciencPharmaceuticals & Biotechnology0.79105850367.18
EquityAkums DrugsPharmaceuticals & Biotechnology0.76151526464.54
EquityAstrazeneca PharPharmaceuticals & Biotechnology0.676256856.46
EquityIndoco RemediesPharmaceuticals & Biotechnology0.56183492447.00
EquityOrchid PharmaPharmaceuticals & Biotechnology0.4545756138.12
EquityConcord BiotechPharmaceuticals & Biotechnology0.1911173815.84

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
6,63,683.95
Trustee/s:
Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda, Mr. Takayuki Murai
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Sailesh Raj Bhan
Auditors:
Haribhakti & Co LLP Chart

OTHER INFORMATION

Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.